Formulations Of A Src/Abl Inhibitor

Patent No. EP1885339 (titled "Formulations Of A Src/Abl Inhibitor") was filed by Bristol Myers Squibb on May 4, 2006. The application was issued on Jul 29, 2015.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
FRESENIUS KABI DEUTSCHLANDApr 29, 2016FRESENIUS KABI DEUTSCHLAND
GENERICS UKApr 29, 2016ELKINGTON AND FIFE
AECHTERApr 28, 2016TER MEER UND PARTNER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP1885339

BRISTOL MYERS SQUIBB
Application Number
EP06769997A
Filing Date
May 4, 2006
Status
Revoked
May 29, 2021
Publication Date
Jul 29, 2015